Beyond the Label: A New Framework for Allergen Detection
Fourteen declared allergens. Millions at risk. And testing methods that still can't keep up with modern food production. We map the detection landscape and where the real opportunity lies.
Introduction
Allergens represent a critical safety and compliance challenge across the entire food and beverage value chain, affecting everything from confectionery and dairy to meat and alternative proteins. Effective allergen management is not just a regulatory requirement but a fundamental pillar of consumer safety and brand trust. A single mislabeling incident can result in fatal consequences and irreparable damage to a company’s reputation. While standard declaration requirements exist (e.g., 9 major allergens in the USA and 14 in the UK/EU), current testing methods often represent a production bottleneck due to slow turnaround times or narrow diagnostic ranges.
Market Context
The global food safety testing market was valued at USD 24.24 billion in 2024 and is projected to reach USD 44.06 billion by 2032 (7.85% CAGR). Within this, the specialized allergen testing market is expected to grow from USD 680 million to USD 1.15 billion by 2032. This segment is driven by several macro tailwinds:
Stricter Regulatory Frameworks: Laws like “Natasha’s Law” (UK) and the “FASTER Act” (USA) increase legal liability for undeclared allergens.
Rising Prevalence: Food allergies affect an estimated 220 million people globally, with a marked increase in life-threatening hospitalizations (e.g., a 61% increase in England over the last two decades).
Clean Label Demand: Consumers increasingly view allergen transparency as a hallmark of premium, trustworthy brands.
The Problem: a failing infrastructure
The global food system is struggling with an allergen management infrastructure that is manual, inconsistent, and prone to failure. As supply chains become more complex and globalized, the risk of cross-contamination and mislabeling has reached a critical point.
Healthcare experts are increasingly recognizing food allergies as a global public health concern, both in developed and less developed countries. Globally roughly 220 million people are affected by food allergies. In the US, 8% of children and up to 11% of adults suffer from at least one food allergy, with 40% of affected children having multiple food related allergies. For example, food allergy related hospitalisations in England increased from 1’971 in 2003 to 5’013 in 2023 (61% increase).
The conventional allergen system is failing at multiple levels. Firstly, the supply chain volatility caused by inadequate cleaning of containers, lack of physical separation during transport, and the accidental inclusion of foreign matters (seeds, grains, cross contamination) create invisible risks. Secondly, human errors during production sequencing, misprints during label development and lack of robust change management when switching suppliers can all lead to undeclared allergens in finished goods. Lastly, for restaurants and food services, failure to receive or communicate accurate ingredient changes from suppliers, coupled with inadequate storage separation in these establishments, leaves the final consumer vulnerable.
The bottleneck: Current detection methods are either too slow (lab-based slow turnaround), too narrow (single-allergen kits), or too expensive for continuous deployment across the entire supply chain. The industry lacks a real-time, multi-allergen detection system that can be integrated seamlessly across every step of the supply chain, rather than isolated checks at single points.
Solution Pathways
There is no “one size fits all” solution, but several core technologies are competing to bridge the safety gap - these range from traditional lab-based molecular diagnostics to emerging digital and sensor-based platforms.
Visual QA
This remains the most widely used starting point: human inspection of ingredients, labels, and production line changeovers. Fast and cheap, but blind to trace-level contamination and difficult to scale without automation. A necessary baseline, not a solution.
Rapid Immunoassays
Lateral flow devices (LFDs) and ELISA kits - uses antibodies to detect allergenic proteins. LFDs deliver a yes/no result in minutes, making them popular for environmental swabs; ELISA adds quantification. The limitation: food processing degrades proteins and distorts results, and most kits target a single allergen at a time.
PCR & Molecular Diagnostics
Detects DNA from an allergenic ingredient with high specificity, even in heavily processed foods. The catch is fundamental - allergies are triggered by proteins, not DNA, so PCR cannot directly measure allergenic risk. It also requires trained lab staff and turnaround times that slow production.
Mass Spectrometry
This is the gold standard for confirmation - capable of identifying multiple allergenic proteins in a single run with high precision. But cost, complexity, and processing times of up to 72 hours make it impractical for routine in-line testing.
Consumer Portable Devices
At home devises brings testing to the dinner table, pairing compact hardware with mobile apps. Promising for consumer confidence, but results apply only to the tested sample portion and real-world accuracy remains inconsistent. E.g. AllergenAlert (FR): Developing consumer “pocket technology” for live testing and QA.
AI & Computer Vision
Analyzing images, labels, hyperspectral data, and sensor outputs to flag allergen risk - non-destructively and at scale. The key limitation: these methods identify allergen-containing ingredients, but cannot detect contamination at a molecular level. Validation against analytical methods remains essential. E.g. LiberEat (UK): Software for allergen labeling detection and compliance
Biosensors & IoT Monitoring
This represents the emerging frontier - antibody and nucleic-acid based sensors designed for continuous, on-site detection. Sensitivity is promising, but standardization and regulatory acceptance are still catching up.
Traceability Platform (ERP, supplier data systems)
These systems round the stack - not detection tools per se, but critical infrastructure for managing allergen risk across complex supply chains and accelerating recalls when incidents occur.
Impact
Nutritional and Population Health Impact
Reliable allergen detection is a life-saving technology. With 40-50% of allergic individuals having experienced anaphylaxis, robust management significantly reduces the risk of emergency hospitalizations and long-term health complications. Furthermore, it provides “peace of mind” for a growing segment of the population that currently avoids eating out due to safety fears.
Economic and Social Impact
Effective management reduces the massive costs associated with product recalls (average direct cost of a recall hits USD 10 million) and legal lawsuits, which can bankrupt smaller CPG brands. For the restaurant and catering sectors, it enables broader market access to the “allergy-conscious” consumer, a demographic with significant and growing purchasing power.
Key Takeaways
Investment Criteria & Opportunities
From an investor perspective, backable ventures must solve the core bottleneck: current testing is too slow, too narrow, and/or too expensive.
What we look for in a fundable allergen safety company:
Multi-allergen capability: Industry needs a “one-stop” check rather than multiple kits
Real-time integration: Speed is critical for short shelf life products
Processed Food Accuracy: Detecting denatured proteins in processed foods is the ultimate technical hurdle
Regulatory Validations: Early navigation of FDA/EFSA/AOAC standards is mandatory for commercialization
Unknowns
The unknowns with each investment opportunity will depend on which technological approach they are taking. One of the biggest unknown which is consistent among all approaches, is that only a sample of the entire product is taken to be tested. Hence, some false negatives will happen as allergen contamination is heterogeneous - a small test portion can miss a hotspot.
We believe the “holy grail” of the sector; being a real-time, multi-allergen, supply-chain-integrated solution, is not yet fully realized at scale. However, we see meaningful opportunities for ventures that can deliver faster, cheaper, and more reliable detection.
Risks
Key risks include the potential for underperformance in real-world conditions versus controlled lab settings, where complex food matrices and processing effects can materially reduce sensitivity and increase false negatives. Specificity is another concern: cross-reactivity and multiplex interference may lead to false positives, undermining customer trust and creating costly operational consequences.
Operationally, sampling representativeness remains a structural challenge, as allergen contamination is often heterogeneous and can be missed by small test portions, while workflow complexity and operator error risk can degrade reliability at scale.
Finally, from a commercialization perspective, adoption may be constrained by long validation and procurement cycles, particularly where AOAC/ISO/FDA-aligned validation is required and results must be defensible for regulated decisions such as labeling, supplier acceptance, and recall actions.
Conclusion and OB positioning
With a fast growing market size and allergen prevalence in populations globally, innovations in methodologies for allergen detection at every step of the supply chain is crucial. In the current state, the “holy grail” of allergen management: a real time, multi allergen, supply chain integrated solution, is not yet fully realized at scale. While portable devices like AllergenAlert and digital checkers like LiberEat are showing promise, the market remains fragmented.
Potential
The long-term upside is meaningful if a venture can deliver faster, cheaper and more reliable allergen detection that fits seamlessly into real production workflows. As food manufacturers face rising complexity in ingredients and supply chains, and increasing scrutiny on labeling and cross contact controls, a step change in multi allergen capability, processed food accuracy, and real time integration could unlock broad adoption across QA, supplier verification, and release testing.
If executed well, ventures in this space can secure high-margin, recurring revenue through consumables or software, while expansion into adjacent traceability and compliance workflows offers substantial long-term upside.
 |
|